RxSight, Inc. (RXST)
6.26
+0.01
(+0.16%)
USD |
NASDAQ |
Aug 24, 16:00
6.255
0.00 (0.00%)
After-Hours: 20:00
RxSight Max Drawdown (5Y) : 92.86% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 92.86% |
| June 30, 2026 | 92.86% |
| May 31, 2026 | 91.71% |
| April 30, 2026 | 90.53% |
| March 31, 2026 | 90.53% |
| February 28, 2026 | 89.66% |
| Date | Value |
|---|---|
| January 31, 2026 | 89.66% |
| December 31, 2025 | 89.66% |
| November 30, 2025 | 89.66% |
| October 31, 2025 | 89.66% |
| September 30, 2025 | 89.66% |
| August 31, 2025 | 89.66% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Precision Optics Corp., Inc. | 50.72% |
| Alcon AG | 37.88% |
| The Cooper Cos., Inc. | 48.24% |
| UFP Technologies, Inc. | 48.31% |
| TransMedics Group, Inc. | 73.69% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.84 |
| Beta (5Y) | 1.129 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.91% |
| Historical Sharpe Ratio (5Y) | -0.3408 |
| Historical Sortino (5Y) | -0.5983 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.34% |